Iron deficiency anaemia Clinical Trials

7 recruiting

Iron deficiency anaemia Trials at a Glance

7 actively recruiting trials for iron deficiency anaemia are listed on ClinicalTrialsFinder across 5 cities in 4 countries. The largest study group is Phase 3 with 3 trials, with the heaviest enrollment activity in Kingston, Regina, and Tampere. Lead sponsors running iron deficiency anaemia studies include Metro North Health Services Royal Brisbane and Women's Hospital, Professor David Johnson, and Menzies School of Health Research.

Browse iron deficiency anaemia trials by phase

Treatments under study

About Iron deficiency anaemia Clinical Trials

Looking for clinical trials for Iron deficiency anaemia? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Iron deficiency anaemia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Iron deficiency anaemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Phase 2

Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery

Cardiac SurgeryChronic Iron Deficiency Anaemia
University Health Network, Toronto60 enrolled3 locationsNCT06287619
Recruiting

Non-invasive Detection of Iron Deficiency in Obstetrics

Iron-deficiencyPostpartum DepressionIron Deficiency Anemia of Pregnancy+5 more
Wuerzburg University Hospital500 enrolled1 locationNCT07083492
Recruiting
Phase 3

Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy

Iron Deficiency Anaemia in Childbirth
Saskatchewan Health Authority - Regina Area280 enrolled1 locationNCT05251493
Recruiting

Maternal Iron Deficiency and Childhood Health

Iron Deficiency Anaemia in Childbirth
Tampere University Hospital6,000 enrolled1 locationNCT06879080
Recruiting
Phase 2

IV iron infusion therapy in patients with persistent pain

Iron deficiency anaemia
Metro North Health Services Royal Brisbane and Women's Hospital160 enrolled1 locationACTRN12622000412730
Recruiting
Phase 3Phase 4

Rapid Iron Infusion Study- a randomised controlled trial (RCT) of the treatment of iron deficiency anaemia in children (RIIS)

Childhood Iron Deficiency Anaemia
Menzies School of Health Research226 enrolled2 locationsACTRN12617001273370
Recruiting
Phase 3

A randomised controlled trial of oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)

Iron deficiency anaemia
Professor David Johnson60 enrolled1 locationACTRN12609000432213